239 filings
Page 10 of 12
8-K
5dcpvktl uuk5w
25 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
8ep8m
15 Dec 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
onv 5mt2h
16 Nov 17
Results of Operations and Financial Condition
12:00am
8-K
xtaxb8pfwkm6tv
3 Nov 17
Eleven Biotherapeutics Prices of $8.0 Million Underwritten Public Offering
12:00am
8-K
v5if0t hivp
20 Oct 17
Other Events
12:00am
8-K/A
vgtu0d l8ru65dyahncc
18 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K
dbw99gj5
13 Oct 17
Departure of Directors or Certain Officers
12:00am
8-K
z2cvznnq43xw5x
22 Sep 17
Eleven Biotherapeutics Announces Completion of Vicinium Manufacturing for Ongoing Clinical Trials in Non-Muscle Invasive Bladder Cancer
12:00am
8-K
xninz
14 Aug 17
Eleven Biotherapeutics Reports Second Quarter 2017 Financial Results
12:00am
8-K
st0yuxbq ajrf15pi5
12 Jun 17
Departure of Directors or Certain Officers
12:00am
8-K
ko3t7ajnqsa5wvlvw3
22 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
4rsf2
4 May 17
Eleven Biotherapeutics Reports First Quarter 2017 Financial Results
12:00am
8-K
hyo0mh
1 May 17
Other Events
12:00am
8-K
rdc5pvcs
3 Apr 17
Other Events
12:00am
8-K
cgnsdtth ncz
24 Mar 17
Eleven Biotherapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
12:00am
8-K
7r6ilb tqa
6 Mar 17
Departure of Directors or Certain Officers
12:00am
8-K
nbo6rimphzqq
6 Jan 17
Other Events
12:00am
8-K/A
cuy2g2k
6 Dec 16
Index to Consolidated Financial Statements
12:00am
8-K
4j181 jwy
14 Nov 16
Eleven Biotherapeutics Reports Third Quarter 2016 Financial Results
12:00am
8-K
x8pqhw97ul8e6m6tcxfp
19 Oct 16
Termination of a Material Definitive Agreement
12:00am